Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1
NCT ID: NCT05006924
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2021-12-10
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1
NCT05560438
Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.
NCT01963897
Observational Prolonged Trial in Myotonic Dystrophy Type 1
NCT02118779
A Registered Observational Cohort Study of Myotonic Dystrophy Type 1
NCT06979024
A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China
NCT06101940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unable to perform functional tests
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Haukeland University Hospital
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristin Ørstavik
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristin L Ørstavik, PHD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Hilde S Robinson, PHD
Role: STUDY_DIRECTOR
University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Oslo University Hispital
Oslo, , Norway
Frambu Centre for Rare Disorders
Siggerud, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
255164
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.